4/12
10:08 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Medium
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
4/12
09:53 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
3/8
11:33 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
3/8
11:33 am
ptct
Rating for PTCT
Low
Report
Rating for PTCT
3/1
10:31 am
ptct
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Medium
Report
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
3/1
10:28 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
3/1
10:28 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
3/1
09:38 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
1/26
12:41 pm
ptct
Rating for PTCT
Low
Report
Rating for PTCT
1/26
10:27 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT
1/26
10:27 am
ptct
Rating for PTCT
Medium
Report
Rating for PTCT